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Abstract 
Oxidative modification of low density lipoproteins (LDL) can increase the atherogenicity of LDL Here we demonstrate the potential role of nitric 
oxide (NO) in LDI, modification. Dose-dependent alterations of LDL including an increase in electrophoretic mobility, generation of peroxides and 
degradation of apoprotein B occurred during ~cubation with NO. Sodium nitroprusside was also shown to increase the el~tromobili~ of LDL. 
Superoxide dismutase (SOD) and catalase did not affect this result. NO treatment also increases the negative charges on other lipoproteins. In addition, 
we have demonstrated that NO plays a protective role in macrophage or superoxide-induced LDL modification through its neutralizing action. 
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1. Introduction 
Oxidative modification of human lipoproteins, espe- 
cially the low density lipoprotein (LDL), is considered to 
be an important step in the development of atherosclero- 
sis [l J. Lipoproteins can be modified by cell-free systems 
and by free-radical-generating cells [2-4]. This modifica- 
tion is accompanied by a number of striking changes, 
including a marked increase in electrophoretic mobility 
[5], hydrolysis of lecithin to lysolecithin, degradation of 
apoprotein B 161, and the generation of peroxides 171. 
Even during the early stages of oxidation, cytotoxic 
products are released and may impair the function of the 
endothelium and other cell types. But, in the presence of 
a-tocopherol or butylated hydroxytoluene, which are ef- 
fective free radical scavengers, the fo~ation of perox- 
ides and most of the other changes are inhibited both in 
vitro and in vivo [7]. 
The species of those free-radicals responsible for the 
oxidation of LDL are not well established. One of the 
reactive radicals which always produces conflicting re- 
sults is nitric oxide (NO). Bruckdorfer et al. [8] reported 
that NO alone had no direct oxidative action on LDL or 
on erythrocyte membranes. In contrast, Jessup et al. [9] 
reported that incubation with NO alone caused oxida- 
tion of LDL and accumulation of small amounts of lipid 
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hydroperoxide. Furthermore, NO was known to inhibit 
the oxidation of LDL in the presence of myoglobin and 
H202. However, in the presence of excess H,O,, the ac- 
tion of NO is totally different and appears to enhance the 
oxidation of the LDL [lo]. Recently, NO was thought to 
enhance the lipid peroxidation of LDL in macrophages 
[9], but was then found to exert a protective role in 
macrophage-mediated LDL peroxidation [1 I]. 
In this study, we first ascertained that oxidative mod- 
ification by NO occurs in vitro in VLDL, LDL, HDL, 
and HDL,. We also demonstrated that NO could exert 
a protective role in superoxide-mediated oxidation of 
LDL. 
2. ~at~ials and methods 
2.1. Chemicals 
The following chemicals were purchased from Sigma Chemical Co. 
(St Louis, MO): potassium superoxide, hemoglobin, sodium dithionite, 
SOD, catalase, nitroprusside, polyacrylamine and sodium dodecylsul- 
fate (SDS). Sodium nitrate, thiobarbituric acid and trichloroacetic acid 
were obtained from E. Merck (Da~s~dt). Protein markers were pur- 
chased from Bio-Rad Laboratories (Richmond, CA). Bovine serum 
albumin (BSA), Penicillin G and Streptomycin were obtained from 
Boehringer Mannheim Biochemical ~ndiana~lis, IN). 
2.2. Preparation of lipoproteins 
Very low density lipoprotein (VLDL) @ < 1.019), LDL @ = 1.019- 
1.063), high density lipoprotein (HDLJ @ = 1.085-L. 125X and HDL, 
@ = 1,125-l .21) were isolated through sequential ultra~nt~fugations 
of plasma from healthy human subjects. Lipoproteins used for oxida- 
tive modification were extensively dialyzed against 0.012 M phosphate- 
buffered saline containing penicillin G (100 units/ml) and streptomycin 
(100 units/ml) and stored at 4% Bio Rad protein assay solutions were 
used for protein determinations, employing BSA as a standard. 
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2.3. Preparation of the NO saturated solution and treatment of LDL 
Distilled water was aerated with pure nitrogen for 2 h before the 
preparation of the NO solution and was kept sealed until use. NO gas 
(Linde Air Products Co.) was then passed through a trap containing 
saturated solutions of NaOH to remove traces of NOz- and N203, and 
then the gas was passed through oxygen-free, nitrogen-treated water for 
30 min to produce an NO-saturated solution. The conversion of hemo- 
globin to methemoglobin determined by a double-beam spectro- 
photometer (Hitachi Model U-3210) was used to analyze the NO con- 
tent of the stock solution [K?]. The NO solution was prepared in vials 
sealed with a rubber septum, and samples were removed anaerobically 
using a gastight syringe. LDL solutions were dispensed into sealed and 
deoxygenated vials. Aliquots of the saturated NO solution were then 
added directly to the LDL solution to give the indicated final concentra- 
tions. 
2.4. Preparation of the ~per~xide anion radical solution 
Pieces of potassium superoxide, approximately 75 mg, were dissolved 
under a swirling motion in 25 ml of ice-cold 50 mM NaOH nlus 0.5 mM 
diethylenetria&ine pentaacetic acid. The resulting solution initially con- 
tained approximately 15 mM H,O, and 8 mM superoxide anion [ 131. 
2.5. Assessment of lipoprotein mod@cation 
The extent of lipid peroxidation was measured in terms of thiobar- 
bituric acid-reactive substances (TBARS) using malondialdehyde as a 
standard 1141. The electrophoretic mobility of the lipoproteins was 
evaluated by the Paragon lipo electrophoresis ystem (Beckman ana- 
lytic, Milan, Italy). In addition, non-enzymatic oxidative cleavage of 
peptide bonds in apoprotein B-100 was performed by SDS-poly 
acrylamine gradient gel electrophoresis [6], The LDL samples were 
dissolved in sample buffer containing 3% SDS, 10% glycerol and 5% 
2-mercaptoethanol, and incubated in boiling water for 5 min. Vertical 
gel electrophoresis was then performed using a 3-12% gradient mini gel 
at a constant current of 30 mA for 3 h in a BDH electrophoresis unit. 
Proteins of known molecular weight were used as standards 
(phosphorylase B, 106 kDa; BSA, 80 kDa). Staining was performed 
using silver nitrate in water containing 0.18 M NH, and 20 mM NaOIi. 
3. Results 
3, i. exudative modl~cat~on of LIIL by NO in cell-free 
systems 
Concentration-dependent and marked alterations in 
the physicochemical properties of LDL occurred when 
LDL was exposed to NO concentrations comparable to 
those produced by macrophage cultures (NO,-/N02-, 
17.4 rt 0.4-271.2 ? 4.9 PM, [Is]> and by C,H/HeJ mice 
(urinary nitrate, 3-94 pmol per mouse, f15]) over a 24 
h period. These alterations comprised of an increase in 
electrophoretic mobility and in the generation of 
thiobarbitu~c acid-reactive substances (TBARS) (Fig. 
lA,B). Non-enzymatic breakdown of LDL apoprotein 
B-100 was also seen (Fig. IC). The 514 kDa band of 
intact apo B gradually diminish~ with increasing radical 
doses. All silver staining of oxidized samples showed a 
diffuse, dark background plus several broad protein 
bands. This fragmentation correlated well with the de- 
gree of lipid peroxidation induced and the net negative 
charge. Fig. 2. shows that LDL can be oxidized by NO, 
but not by other factors such as the pH variation (pH 7.4 
to 6.2), NO,-, or both combined. A deactivated NO 
solution was also used here to exclude the participation 
of divalent metals. Moreover, it was evident that the 
oxidative effects of NO added as a bolus were not de- 
Fig. 1. The changes in LDL (0.4 mg/ml) after incubation with NO for 
24 h were measured by the generation of peroxides (TBARS) (A), the 
increase of electromobility (B), and the degradation of apoprotein B- 
100 (C). The arrow indicates sample origin. Molecular masses are 
indicated in kDa. M, molecular mass markers. 
creased by the slow continuous infusion of NO over time 
which mimics the conditions that occur in vivo (Fig. 3). 
Sodium nitroprusside, which usually acts as a source 
of NO in cell-free systems [16], was also used in this 
study. A dose-dependent increase in the electromobil~ty 
of LDL was observed (Fig. 4). SOD and catalase did not 
affect the movement of LDL. 
3.2. Modification of other lipoproteins by NO in a 
cell-free system 
Other lipoproteins which were isolated through se- 
quential ultracentrifugation of plasma were also used. 
We tested whether there was any difference between na- 
tive and NO-oxidized lipoproteins. When measured 
using Beckman paragon lipo agarose gel electrophoresis, 
the negative charge on VLDL increased after NO treat- 
ment as compared with the native form. The electro- 
phoretic mobility of two treated forms of high density 
lipoproteins, HDL, and HDL,, were also increased (Fig. 
5). The results clearly show that oxidative modification 
occurred in HDL and VLDL as well as in LDL. 
1 23 4 56 
Fig. 2. The influence of pH variation (lane 2), the content of NO,- (0.25 
mM) (lane 3), or both (lane 4) on the oxidative m~ification of LDL. 
Lane 5, LDL without any treatment. Deactivated NO solution (lane 6) 
(deactivated by air exposure for 24 h) was also tested. NO solution (0.25 
mM) was used here for positive control (lane 1). 
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Fig. 3. The influence of the slow continuous infusion of the NO solution 
on the oxidative modification of LDL. Slow continuous infusions of 
NO were performed by adding a definite amount every 4 h (lane 2), 1 
h (lane 3), or 10 min (lane 4) to make a final concentration (0.125 mM) 
equal to that of the bolus added (lane 5). Lane 1, LDL without any 
treatment. 
3.3. Oxidative modtjication of LDL by superoxide 
The alterations of LDL were examined when an NO 
stimulator or NO inhibitor was added to stimulate mac- 
rophages. Our data (not shown) support the finding by 
Yates et al. [I l] that the increase of NO protects against 
macrophage-mediated lipid peroxidation and that the 
inhibition of NO production reverses the phenomenon. 
A conflicting result is indicated here that NO seems to 
accelerate the oxidation of LDL in a cell-free system but 
inhibits it when stimulated macrophages are present. 
One possibility is that NO alone has direct oxidative 
action on LDL, but NO can neutralize the oxidative 
effects of superoxide ions which are also produced by 
macrophage cells. This hypothesis is demonstrated in 
Fig. 6. The superoxide anion-induced increase of anodic 
mobility was reversed or partially restored by co-incuba- 
tion with NO. H,O, did not change the electromobility. 
LDL’s ubiquinol-10 and accumulation of small amounts 
of lipid hydro~roxides. In this study, we observed dose- 
response alterations in the physiological properties of 
LDL when LDL was exposed to an NO concentration 
comparable to those produced by macrophage cultures 
over a 24 h period [ 151. 
A mechanism now widely accepted is that monocytes 
develop into macrophages in the subendothelial spaces 
where LDL is considered to be oxidatively modified. 
Oxidized LDL is then taken up by macrophages, leading 
to foam cell transformations [1,5]. In contrast, HDL is 
involved in the amelioration of the atherosclerotic lesion 
in vivo by way of stimulating a cholesterol e&x from 
the foam cells [18]. However, HDL loses its ability to 
stimulate an efllux of cholesterol from foam cells after 
oxidative modification [19]. The results in Fig. 5 clearly 
show that oxidative modification by NO occurs in HDL 
as well as in LDL. This finding implies that NO may be 
actively involved in the development of atherosclerosis. 
The present study [ZO} reveals that SOD increases the 
half-life of NO, but NO does not bind directly to the 
copper of SOD [21], suggesting that the potency of NO 
as a vasodilator is decreased in the presence of superox- 
ides. Wolin et al. [22] also reported that, by extracellular 
generation of superoxide anions, Methylene blue inhib- 
ited vasodilation due to nitric oxide. It is probable that 
NO can accept electrons and react with superoxides to 
form peroxynitrite anions and thereby inactivate the su- 
peroxides. This reaction has a high yield (~85%) [23]. 
Although Beckman et al. [24] proposed that a homolytic 
fission of the peroxynitrite anion produces a strong oxi- 
dant with reactivity similar to the hydroxyl radical, Hogg 
NP 
0 
l+cizi&s 
3 
4. Discussion 
LDL has been shown to be oxidized by NO-generating 
cells such as macrophages, monocytes or endothelial 
cells [2,3,17]. Moreover, LDL modification by endothe- 
lial cells was not influen~d by SOD, catalase, or single 
oxygen or hydroxyl radical scavengers [3]. In addition, 
although ferryl-myoglobin-mediated peroxidation of 
LDL may be enhanced or suppressed by NO depending 
on the relative concentration of NO and hydrogen perox- 
ides [lo], the action of NO on enhancing LDL oxidation 
suggests that under certain conditions NO may have 
disadvantageous effects [S]. Jessup et al. [9] also reported 
that incubation with NO alone caused oxidation of 
1 
0.3 
0.1 
CmM3 f 
Fig. 4. Electrophoretic mobility of LDL (0.4 mg/ml) after incubation 
with nitroprusside for 24 h. The influence of SOD (600 units/ml) and 
catalase (600 unit~m~) on the net negative charge of LDL was also 
tested. The arrow indicates sample origin. NP, nitroprusside. 
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Fig. 5. El~trophoretic mobility of VLDL (0.4 mgfml) (A), HDL, (0.4 mgJm1) (B), and HDL, (0.4 mglml) (C) were measured after incubation with 
NO for 24 h. Arrows indicate sample origins. 
0.125 
0.0625 
et al. [25] showed that there was low efficiency in produc- 
tion of hydroxyl radicals from the simultaneous presence 
of superoxides and NO. The maximum yield of hydroxyl 
radicals produced were about 3% of the concentration of 
3-mo~holinosydnoni~ne ~-ethyl~rbamide (SIN-l) 
decomposed. In addition, although it is not yet known 
what level of hydroxyl radical generation can be re- 
A + 
NO - 0.5 0.5 - - tmM1 
0; - - 2.0 2.0 - cmM1 
NO - 0.5 0.5 - - [mMl 
0; - - -2.s 2.5 - tmMf 
c 
3, 
NO - 0.5 0.5 - - [mMl 
0; - - 2.5 2.5 - [mMl 
Fig. 6. The intIuence of NO on superoxide-mediated oxidation of LDL 
was measured by agarose gel electrophoresis. NO and superoxide were 
added at the same time (A,B). A 30-min time lag between the addition 
of NO and superoxide (C). Arrows indicate sample origins. 
garded as deleterious, the effects of several oxygen-cen- 
tered free radicals on human LDL were examined by 
Bedwell et al. [26] who found that the hydroxyl radical 
alone had a low ability to produce modified LDL. 
Hogg et al. [27] and Darley-Usmar et al. [28] have 
recently demonstrated that the simultaneous generation 
of superoxides and NO by the xanthine oxidasels-ni- 
troso-~-acetylpenicillamine system or the SIN-l com- 
pound resulted in the formation of an oxidant with ‘hy- 
droxyl-radical like’ reactivity capable of initiating the 
oxidation of LDL. We also observed a similar result 
when 1.2.4-benzentriol/nitroprusside system was used to 
generate these two radicals in the presence of LDL (data 
not shown). However, there is poor evidence that the 
hydroxyl radical itself mediated this modification. Fur- 
thermore, it was found that SIN-l is attacked by molec- 
ular oxygen and is converted to a radical while oxygen 
is reduced to a superoxide, and the resulting highly un- 
stable radical is stabilized by NO splitting off and depro- 
tonating 1291. This finding implies that the time interval 
between superoxide fo~ation and NO formation may 
be sufficient for the highly unstable superoxide radical 
to react with LDL first, Therefore, it is possible that the 
xanthine oxidease/~-nitroso-~-acetylpenicillamine, 1.2.4- 
benzentriol/nitroprusside or SIN- 1 dependent peroxida- 
tion is mediated by the additive effect of these two radi- 
cals. In this study, gas-tight syringes were used to add the 
NO-saturated solution and superoxide stock solution si- 
multaneously to the LDL solution. Fig. 6 clearly indi- 
cates that the superoxide-induced modification was 
reversed when co-incubated with NO, but this modifica- 
tion was additive when there is a 30”minute time lag in 
the addition of NO and superoxide. Thus, NO reacts 
with the superoxide and thereby inactivates it. 
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